학술논문

HCB-ONC001 ELPIS TRIAL: Omission of surgery and sentinel lymph node dissection in clinically low-risk HER2-positive breast cancer with high HER2 addiction and a complete response following standard anti-HER2-based neoadjuvant therapy
Document Type
Journal
Source
ANNALS OF ONCOLOGY; MAY 2022, 33 pS182-pS183, 2p. Supplement: 3
Subject
Language
English
ISSN
15698041